Biomimetic microfluidic device for in vitro antihypertensive drug evaluation.

Microfluidic devices have emerged as revolutionary, novel platforms for in vitro drug evaluation. In this work, we developed a facile method for evaluating antihypertensive drugs using a microfluidic chip. This microfluidic chip was generated using the elastic material poly(dimethylsiloxane) (PDMS) and a microchannel structure that simulated a blood vessel as fabricated on the chip. We then cultured human umbilical vein endothelial cells (HUVECs) inside the channel. Different pressures and shear stresses could be applied on the cells. The generated vessel mimics can be used for evaluating the safety and effects of antihypertensive drugs. Here, we used hydralazine hydrochloride as a model drug. The results indicated that hydralazine hydrochloride effectively decreased the pressure-induced dysfunction of endothelial cells. This work demonstrates that our microfluidic system provides a convenient and cost-effective platform for studying cellular responses to drugs under mechanical pressure.

[1]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[2]  Niraj K Inamdar,et al.  Microfluidic cell culture models for tissue engineering. , 2011, Current opinion in biotechnology.

[3]  S. Oparil,et al.  Essential hypertension. Part I: definition and etiology. , 2000, Circulation.

[4]  Hongkai Wu,et al.  Gradient‐Regulated Hydrogel for Interface Tissue Engineering: Steering Simultaneous Osteo/Chondrogenesis of Stem Cells on a Chip , 2013, Advanced healthcare materials.

[5]  Ali Khademhosseini,et al.  Periosteum‐Mimetic Structures Made from Freestanding Microgrooved Nanosheets , 2014, Advanced materials.

[6]  J. Mcgiff,et al.  Endothelial Mechanism in the Vascular Action of Hydralazine , 1983, Hypertension.

[7]  S. Alper,et al.  Hemodynamic shear stress and its role in atherosclerosis. , 1999, JAMA.

[8]  A. Harris,et al.  Novel Mechanism of Action for Hydralazine: Induction of Hypoxia-Inducible Factor-1 &agr;, Vascular Endothelial Growth Factor, and Angiogenesis by Inhibition of Prolyl Hydroxylases , 2004, Circulation research.

[9]  B. Sumpio,et al.  Cells in focus: endothelial cell. , 2002, The international journal of biochemistry & cell biology.

[10]  Steven M Holland,et al.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. , 2003, The Journal of clinical investigation.

[11]  Hongkai Wu,et al.  One-step generation of engineered drug-laden poly(lactic-co-glycolic acid) micropatterned with Teflon chips for potential application in tendon restoration. , 2013, ACS applied materials & interfaces.

[12]  O. Carretero,et al.  The Loss of Endothelium‐Dependent Vascular Relaxation in Hypertension , 1986, Hypertension.

[13]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[14]  B. Falkner.  Hypertension in children and adolescents: epidemiology and natural history , 2009, Pediatric Nephrology.

[15]  Jason P. Gleghorn,et al.  Microfluidic scaffolds for tissue engineering. , 2007, Nature materials.

[16]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[17]  B. Groves,et al.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.

[18]  Laura E Niklason,et al.  Microfluidic artificial "vessels" for dynamic mechanical stimulation of mesenchymal stem cells. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[19]  E. Tansey.  Oxford Companion to the Body , 2001 .

[20]  N. Tzemos,et al.  Exercise blood pressure and endothelial dysfunction in hypertension , 2009, International journal of clinical practice.

[21]  M. Clozel,et al.  Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. , 1990, Hypertension.

[22]  U. Ryan,et al.  Cell-cell contact mechanisms , 1992, Current Biology.

[23]  Yang Yang,et al.  A microfluidic system for the study of the response of endothelial cells under pressure , 2014 .

[24]  Hongkai Wu,et al.  Enhanced Osteogenesis by a Biomimic Pseudo‐Periosteum‐Involved Tissue Engineering Strategy , 2013, Advanced Healthcare Materials.

[25]  G. Whitesides,et al.  Soft lithography in biology and biochemistry. , 2001, Annual review of biomedical engineering.

[26]  J. Cutler,et al.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 , 2008, Hypertension.

[27]  Hongkai Wu,et al.  Partial transfection of cells using laminar flows in microchannels. , 2011, Biomicrofluidics.

[28]  S. Ostrovidov,et al.  Microfluidic generation of polydopamine gradients on hydrophobic surfaces. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[29]  E. Schiffrin.  Immune mechanisms in hypertension and vascular injury. , 2014, Clinical science.

[30]  Ju Hun Yeon,et al.  Drug permeability assay using microhole-trapped cells in a microfluidic device. , 2009, Analytical chemistry.

[31]  C. Su,et al.  Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. , 1983, Hypertension.

[32]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[33]  Joseph Varon,et al.  Hypertensive crises: challenges and management. , 2007, Chest.

[34]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[35]  Jeremy L. Steinbacher,et al.  Interfacial polymerization within a simplified microfluidic device: capturing capsules. , 2005, Journal of the American Chemical Society.

[36]  T. Stevens.  Functional and molecular heterogeneity of pulmonary endothelial cells. , 2011, Proceedings of the American Thoracic Society.

[37]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[38]  M. Safar,et al.  Arterial and venous compliance in sustained essential hypertension. , 1987, Hypertension.

[39]  Shoji Takeuchi,et al.  Metre-long cell-laden microfibres exhibit tissue morphologies and functions. , 2013, Nature materials.

[40]  Hongkai Wu,et al.  Directing Osteogenesis of Stem Cells with Drug‐Laden, Polymer‐Microsphere‐Based Micropatterns Generated by Teflon Microfluidic Chips , 2012 .

[41]  B. Min.  Effects of Vitamin D on Blood Pressure and Endothelial Function , 2013, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[42]  Federico Vozzi,et al.  Hydrostatic pressure and shear stress affect endothelin‐1 and nitric oxide release by endothelial cells in bioreactors , 2014, Biotechnology journal.

[43]  T. Kotchen.  Historical trends and milestones in hypertension research: a model of the process of translational research. , 2011, Hypertension.

[44]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[45]  T. Saruta,et al.  Pressure enhances endothelin-1 release from cultured human endothelial cells. , 1995, Hypertension.

[46]  Zhongmin Jin,et al.  Fabrication of Nature‐Inspired Microfluidic Network for Perfusable Tissue Constructs , 2013, Advanced healthcare materials.